article thumbnail

Press Release: Silo Pharma Secures Patent that May be Used for Psychedelics Delivery Technology

Cannabis Law Report

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Presently, the company is working with researchers to build out these technologies and pave the way for clinical trials. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

article thumbnail

Prohibition (UK) Publish…. PSYCH: THE PSYCHEDELICS AS MEDICINE REPORT

Cannabis Law Report

Download your free copy now. North America and Europe are home to 142 active, or soon-to-be active, clinical trials focused on the therapeutic potential of psychedelic substances.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MedXtractor Fills a Key Gap in Mental Health Treatments

Cannabis Law Report

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. For more information, visit the company’s website or download their investor presentation. Mental Health Challenges. Disclaimer.

article thumbnail

Cannabis for IBS: Treating Irritable Bowel Syndrome with Medical Marijuana

Greencamp

Cannabis research still has a long way to go regarding this topic, and it will take more clinical trials to fully understand how cannabis helps with IBS. You can download the eBook here for free. Another study also had positive results, but this time using just one compound—CBD. ( How to choose the best strain for IBS?

article thumbnail

Press Release: Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives

Cannabis Law Report

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec. launched their app platform Mindleap 2.0

article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

We also provide free downloadable resources: ‘The Endocannabinoid System and Medical Marijuana in 15 minutes!’ We provide free educational resources, including ‘The Answer of the Day,’ a daily question and answer email that reviews the medical marijuana articles published in the peer-reviewed medical journals.

article thumbnail

Use of Cannabis-based medicinal products: NICE guidelines

Cannabis Law Report

Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. Tools and resources. Recommendations. Recommendations for research. Rationale and impact. Finding more information and committee details. Recommendations. Intractable nausea and vomiting. Chronic pain. Spasticity. Severe treatment-resistant epilepsy.